Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-16-076141
Filing Date
2016-01-20
Accepted
2016-01-19 18:16:10
Documents
1
Group Members
CALEY CASTELEINJAMES SHAPIROKEARNY VENTURE ASSOCIATES, L.L.C.KEARNY VENTURE PARTNERS ENTREPRENEURS' FUND, L.P.RICHARD SPALDINGTHOMAS WEISEL HEALTHCARE VENTURE PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 1 v429206_sc13da.htm SC 13D/A 103129
  Complete submission text file 0001144204-16-076141.txt   104787
Mailing Address 88 KEARNY ST SAN FRANCISCO CA 94108
Business Address 88 KEARNY ST SAN FRANCISCO CA 94108
Kearny Venture Partners LP (Filed by) CIK: 0001376359 (see all company filings)

EIN.: 000000000
Type: SC 13D/A

Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Subject) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88058 | Film No.: 161349333
SIC: 2834 Pharmaceutical Preparations